SCHEMBL16620620

SCHEMBL16620620

CCOC(=O)c1ccc(-c2ccc3nccn3n2)cc1

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
JAK2 O60674 2/20 0.55
RET P07949 2/20 0.55
KDR P35968 2/20 0.55
GSK3A P49840 2/20 0.55
RPS6KA3 P51812 2/20 0.55
LIMK1 P53667 2/20 0.55
MAP2K1 Q02750 2/20 0.55
CLK4 Q9HAZ1 2/20 0.55
ALK Q9UM73 2/20 0.55
DYRK1B Q9Y463 2/20 0.55
AURKA O14965 1/20 0.55
DAPK3 O43293 1/20 0.55
MAP4K4 O95819 1/20 0.55
ABL1 P00519 1/20 0.55
NTRK1 P04629 1/20 0.55
CSF1R P07333 1/20 0.55
FGFR1 P11362 1/20 0.55
PRKACA P17612 1/20 0.55
MAP2K2 P36507 1/20 0.55
MAPK8 P45983 1/20 0.55

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22688959 0.85 KDR (0.59) JAK2RETKDRGSK3ARPS6KA3
SCHEMBL22926416 0.81 JAK2 (0.75) JAK2RETKDRGSK3ARPS6KA3
SCHEMBL3515178 0.81 DYRK1A (0.66) JAK2RETKDRGSK3ARPS6KA3
SCHEMBL21192982 0.80 CYP1A2 (0.45) JAK2RETKDRGSK3ARPS6KA3
SCHEMBL16621291 0.78 DYRK1A (0.62) JAK2RETKDRGSK3ARPS6KA3
SCHEMBL16621332 0.78 DYRK1A (0.52) RETDYRK1AMAOBCA12CA1
SCHEMBL15286376 0.78 MAOB (0.45) MAOBJMJD6CA12CA1CA2
SCHEMBL16620726 0.77 NPC1 (0.49) DYRK1BDYRK1AMAOBCA12CA1
SCHEMBL20993472 0.74 JMJD6 (0.54) ABL1JMJD6CA12CA1CA2
SCHEMBL2251313 0.74 ESR1 (0.47) MAOBJMJD6CA12CA1CA2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3052501-B1 BICYCLIC ALKYNE DERIVATIVES AND USES THEREOF AGENCY SCIENCE TECH & RES (SG) 2022-06-22 EP disclosed
US-10544149-B2 Bicyclic alkyne derivatives and uses thereof AGENCY FOR SCIENCE, TECHNOLOGY AND RESEARCH (SG) 2020-01-28 US disclosed
US-20180194771-A1 BICYCLIC ALKYNE DERIVATIVES AND USES THEREOF AGENCY FOR SCIENCE, TECHNOLOGY AND RESEARCH (SG) 2018-07-12 US disclosed
US-9884867-B2 Bicyclic alkyne derivatives and uses thereof AGENCY FOR SCIENCE, TECHNOLOGY AND RESEARCH (SG) 2018-02-06 US disclosed
US-20160229860-A1 BICYCLIC ALKYNE DERIVATIVES AND USES THEREOF AGENCY FOR SCIENCE, TECHNOLOGY AND RESEARCH (SG) 2016-08-11 US disclosed
EP-3052501-A1 BICYCLIC ALKYNE DERIVATIVES AND USES THEREOF Agency For Science, Technology And Research (SG) 2016-08-10 EP disclosed
WO-2015050505-A1 BICYCLIC ALKYNE DERIVATIVES AND USES THEREOF AGENCY FOR SCIENCE, TECHNOLOGY AND RESEARCH (SG) 2015-04-09 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160229860-A1 BICYCLIC ALKYNE DERIVATIVES AND USES THEREOF MAPKAPK2, CAMKK2, MKNK2 JAK2 505/4885RET 515/4885KDR 2685/4885
US-10544149-B2 Bicyclic alkyne derivatives and uses thereof MAPKAPK2, MAP4K2, MKNK2 JAK2 513/4885RET 524/4885KDR 2824/4885
US-20180194771-A1 BICYCLIC ALKYNE DERIVATIVES AND USES THEREOF MAPKAPK2, CAMKK2, MKNK2 JAK2 505/4885RET 515/4885KDR 2685/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.